Literature DB >> 27158912

Myrtenal alleviates hyperglycaemia, hyperlipidaemia and improves pancreatic insulin level in STZ-induced diabetic rats.

Rathinam Ayyasamy1, Pari Leelavinothan1.   

Abstract

CONTEXT: Myrtenal is monoterpene a constituent of essential oils found mainly in herbs such as mint, pepper, cumin, etc. It exerts admirable pharmacological activities against many diseases including diabetes. Hyperlipidaemia is a secondary complication of diabetes and also a major risk factor for cardiovascular diseases.
OBJECTIVE: The present study investigated the possible antihyperlipidaemic efficacy of myrtenal on plasma glucose, pancreatic insulin, plasma and tissue lipid levels in streptozotocin (STZ) induced diabetic rats.
MATERIALS AND METHODS: Diabetes was induced in male Wistar rats by a single intraperitoneal injection of STZ (40 mg/kg b.w.). Myrtenal (80 mg/kg) was administered orally to diabetic rats for a period of 28 d. Plasma glucose, pancreatic insulin, TC, TGs, FFAs, PLs, LDL-C, HDL-C, VLDL, atherogenic index, (HMG-CoA) reductase, LPL, LCAT and liver histology were analyzed.
RESULTS: Diabetic rats showed significantly (p < 0.05) increased plasma glucose (273.18 mg/dL), total cholesterol (142 mg/dL), triglycerides (126 mg/dL), free fatty acids (118 mg/dL), phospholipids (153 mg/dL), low-density lipoprotein (88.07 mg/dL), very low-density lipoprotein (25.2 mg/dL), atherogenic index, whereas a decrease in the levels of pancreatic insulin (97.48 ng/mg) and high-density lipoprotein (29.12 mg/dL). In addition, the activity of 3-hydroxy 3-methylglutaryl coenzyme A (HMG-CoA) reductase (0.94 HMG-CoA ratio/(mevalonate) increased significantly in contrast to the activities of lipoprotein lipase (4.87 μmoles of glycerol liberated/h/L) and lecithin cholesterol acyltransferase (54.61 μmoles of cholesterol esterified/h/L) in diabetic rats. Treatment with myrtenal significantly (p < 0.05) improved the levels of plasma glucose, pancreatic insulin and lipid profiles. Moreover, the histopathological analysis of liver was also in agreement with the biochemical findings. DISCUSSION AND
CONCLUSIONS: The present study indicates that myrtenal possess antihyperglycaemic and antihyperlipidemic properties, and could potentially be a useful phytochemical in treating diabetes.

Entities:  

Keywords:  Antihyperglycaemic; antihyperlipidaemic; atherogenic index; histopathology

Mesh:

Substances:

Year:  2016        PMID: 27158912     DOI: 10.3109/13880209.2016.1168852

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

1.  Anti-atherosclerotic Effects of Myrtenal in High-Fat Diet-Induced Atherosclerosis in Rats.

Authors:  Liyan Yu; Hongguang Liu; Xiaoxia Ma; Vidya Devanathadesikan Seshadri; Xuan Gao
Journal:  Appl Biochem Biotechnol       Date:  2022-07-09       Impact factor: 2.926

Review 2.  Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

3.  Effect of N-Acetylcysteine on Dyslipidemia and Carbohydrate Metabolism in STZ-Induced Diabetic Rats.

Authors:  Anderson Kiyoshi Kaga; Pedro Octavio Barbanera; Nágilla Orleanne Lima do Carmo; Lucas Rodolfo de Oliveira Rosa; Ana Angélica Henrique Fernandes
Journal:  Int J Vasc Med       Date:  2018-01-28

4.  Synthesis and Cytotoxic Analysis of Novel Myrtenyl Grafted Pseudo-Peptides Revealed Potential Candidates for Anticancer Therapy.

Authors:  Odette Concepción; Julio Belmar; Alexander F de la Torre; Francisco M Muñiz; Mariano W Pertino; Barbara Alarcón; Valeska Ormazabal; Estefania Nova-Lamperti; Felipe A Zúñiga; Claudio A Jiménez
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

Review 5.  In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update.

Authors:  Lina T Al Kury; Aya Abdoh; Kamel Ikbariah; Bassem Sadek; Mohamed Mahgoub
Journal:  Molecules       Date:  2021-12-29       Impact factor: 4.411

6.  Hepatoprotective Effect of Actinidia deliciosa against Streptozotocin-Induced Oxidative Stress, Apoptosis, and Inflammations in Rats.

Authors:  Fatma M El-Demerdash; Yousra Talaat; Raghda A El-Sayed; Wenyi Kang; Nora F Ghanem
Journal:  Oxid Med Cell Longev       Date:  2022-03-19       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.